ArticleBMC geriatrics2026
Comorbidity phenotypes and the incidence and severity of acute kidney injury in older critically ill patients: a retrospective cohort study.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impact of specific comorbidity combinations on the risk and severity of acute kidney injury (AKI) in older critically ill patients remains unclear. This study aimed to identify comorbidity phenotypes using latent class analysis (LCA) and quantify their associations with hospital-acquired AKI.
methodsWe conducted a retrospective study using the MIMIC-IV database on first-time ICU patients (> 65 years) with a length of stay ≥ 48 h. Patients with baseline chronic kidney disease (CKD) or early-onset AKI were excluded. LCA was applied to baseline chronic conditions to identify distinct comorbidity phenotypes. Subsequently, we employed multivariable Cox proportional hazards models to evaluate AKI incidence, and logistic regression to assess AKI severity (KDIGO Stage ≥ 2), adjusting for potential confounders.
resultsOf 5,721 eligible patients, 2,202 (38.5%) developed hospital-acquired AKI. LCA identified five phenotypes: Class 1 (Low Comorbidity), Class 2 (Respiratory & Nicotine), Class 3 (Isolated Metabolic & Atherosclerosis), Class 4 (Atrial Fibrillation & Complex Cardiac), and Class 5 (Ischemic Heart Failure). Compared to Class 1, Class 4 showed the highest AKI risk (HR 1.52, 95% CI 1.29-1.79, P < 0.001), followed by Class 5 (HR 1.41, 95% CI 1.20-1.65, P < 0.001). Class 2 (HR 1.34) and Class 3 (HR 1.14) also had elevated risks. Notably, secondary analysis revealed that Class 4 (OR 1.87) and Class 5 (OR 1.51) were strongly associated with progression to moderate-to-severe AKI, whereas Class 3 was not. Furthermore, in a Fine-Gray competing-risk model treating in-hospital death before AKI occurrence as the competing event, these associations remained generally consistent.
conclusionDistinct comorbidity phenotypes significantly influence the incidence and severity of hospital-acquired AKI. Phenotypes characterized by Atrial Fibrillation and Ischemic Heart Failure represent the highest-risk groups for severe renal outcomes, highlighting the potential value of targeted renal surveillance and individualized hemodynamic management in older critically ill patients.
Indexed as
Identifiers
42481936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.